Meeting
2023 ASCO Gastrointestinal Cancers Symposium
Cytoreductive surgery and HIPEC in colorectal cancer peritoneal metastases (CRPM): Real-world outcomes in systemic anticancer treatment–naïve patients.
Authors
Nadina Tinsley
University of Manchester, Manchester, United Kingdom;
Nadina Tinsley , Raghavendar Nagaraju , Sarah O'Dwyer , Michael Braun , Saifee Mullamitha , Konstantinos Kamposioras , Omer Aziz , Jorge Barriuso
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Patient-Reported Outcomes and Real-World Evidence
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 39)
DOI
10.1200/JCO.2023.41.4_suppl.39
Abstract #
39
Poster Bd #
B14
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
Survival according to mutations in BRAF, KRAS, or microsatellite instability (MSI-H) after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal metastases from colorectal cancer.
First Author: Stein G Larsen
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Clinical outcomes of appendix goblet cell adenocarcinoma and role of systemic chemotherapy.
First Author: Madeleine Cornelia Strach
Poster
2017 ASCO Annual Meeting
Effect of postoperative morbidity on survival after cytoreductive surgery (CRS) with heated intraperitoneal chemotherapy (HIPEC) for peritoneal metastasis in a series of 700 cases.
First Author: Clarisse Eveno
Poster
2016 ASCO Annual Meeting
Peritoneal mesothelioma: evaluation of chemotherapeutic agents used for HIPEC through the RENAPE database.
First Author: Brice Malgras